http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100588391-B1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-08
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D319-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-112
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D319-18
filingDate 1998-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2006-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2006-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-100588391-B1
titleOfInvention 1-phenyl-4-benzylpiperazine: dopamine receptor subtype specific ligand (D4)
abstract The present invention relates to a compound of formula (I) or a pharmaceutically acceptable addition salt thereof, wherein the compound is a dopamine D4 (anti) antagonist and is useful for treating schizophrenia, psychotic depression and manic diseases:n n n Formula (I) n n n Wheren n n R 1 is halogen or C 1 -C 4 alkyl;n n n R 2 and R 3 are the same or different and are hydrogen, halogen, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, alkylthio, hydroxy, amino, mono (C 1 -C 4 ) alkylamino, di ( C 1 -C 4 ) alkylamino, orn n n R 2 and R 3 together are an alkenylene moiety having 4 carbon atoms which together with the phenyl ring form a naphthyl moiety.
priorityDate 1997-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD3ZQL7
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID36606
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ27957
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO94811
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7TQD2
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID36606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468309589
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9VV43
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468285491
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466133822

Total number of triples: 41.